COMP <GO>
LICN vs ATXG // RSI-14 & 200D SMA MOMENTUM
Lichen International Limited (Class A) (NASDAQ) VS. Addentax Group Corp. (NASDAQ) • 15-METRIC TALLY: LICN 3
— ATXG 4
▲ RSI-14 & 200D SMA MOMENTUM LEADER: ATXG
LAST: $0.75 (-12.79%) • MKT CAP: $12.3M
rsi-technicals
26.5
LAST: $2.78 (-5.27%) • MKT CAP: $5.9M
rsi-technicals
43.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LICN VS. ATXG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LICN | ATXG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | 14.10% | +81.90 | LICN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.70% | -5.60% | -27.10 | ATXG | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -13.41% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -28.50% | -31.50 | ATXG | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 28.50% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.57 | 0.76 | +0.81 | LICN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | ATXG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 26.5 | 43.9 | -17.42 | ATXG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.3M | $5.9M | $6.5M | LICN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LICN REV | ATXG REV | LICN GROSS % | ATXG GROSS % | LICN FCF | ATXG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $809.0K | $5.4M | 98.0% | 14.1% | -$17.8M | -$784.5K |
| FY 2024 | $0 | $4.2M | — | 15.2% | -$5.6M | $618.4K |
| FY 2023 | $0 | $5.2M | — | — | $557.0K | -$411.5K |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LICN // BETA —
ATXG // BETA —